|1.||Ogasawara, Kazuya: 3 articles (01/2011 - 05/2006)|
|2.||Wei, Xuetuan: 2 articles (02/2015 - 12/2012)|
|3.||Yang, Nae-Cherng: 2 articles (03/2009 - 01/2009)|
|4.||Hwang, Kai-Lin: 2 articles (03/2009 - 01/2009)|
|5.||O'Gara, James P: 1 article (12/2015)|
|6.||McCarthy, Hannah: 1 article (12/2015)|
|7.||Zapotoczna, Marta: 1 article (12/2015)|
|8.||O'Neill, Eoghan: 1 article (12/2015)|
|9.||Rudkin, Justine K: 1 article (12/2015)|
|10.||Thiyur, Swathi: 1 article (10/2015)|
01/01/2010 - "However, in vivo evaluation of the therapeutic efficacy of nattokinase against thrombosis remains to be conducted. "
01/01/2010 - "Previously, the in vitro efficacy of nattokinase against thrombosis had been reported; now our study has revealed the in vivo efficacy of nattokinase against thrombosis."
10/01/2015 - "Nattokinase (NK) is a potent fibrinolytic agent for thrombosis therapy. "
02/01/2015 - "Nattokinase (NK) possesses the potential for prevention and treatment of thrombus-related diseases. "
12/01/2013 - "The results indicate that nattokinase extracted from fermented soybean inhibit platelet aggregation by blocking thromboxane formation, and thereby delay thrombosis following oxidative arterial wall injury. "
01/01/2009 - "A total of 47 patients with hyperlipidemia were assigned to one of three groups: 1. nattokinase-mono formula (50 mg/capsule), 2. combined formula of nattokinase with RYR (300 mg of extract/capsule) and 3. placebo. "
01/01/2009 - "In summary, this study provides long-term efficacy of nattokinase supplementation and shows that the combined formula has relatively more potent effects than the mono formula on lowering of blood lipids, suggesting that combined nattokinase with RYR will be a better neutraceutical for patients with hyperlipidemia than nattokinase alone."
01/01/2009 - "The purpose of this randomized, double-blind, placebo-controlled, parallel comparison study was to evaluate the lipid-lowering effect of orally administrated nattokinase and nattokinase combined with red yeast rice (RYR) extract on blood lipids in patients with hyperlipidemia. "
01/01/2009 - "Combined nattokinase with red yeast rice but not nattokinase alone has potent effects on blood lipids in human subjects with hyperlipidemia."
|3.||Hypertension (High Blood Pressure)
01/01/2011 - "These results suggest that nattokinase and its fragments are different from each other in the mechanism to reduce hypertension. "
01/01/2011 - "To determine whether the antihypertensive effect of nattokinase is associated with the protease activity of this enzyme, we compared nattokinase with the fragments derived from nattokinase, which possessed no protease activity, in terms of the effect on hypertension in spontaneously hypertensive rats (SHR). "
08/01/2008 - "These findings suggest that increased intake of nattokinase may play an important role in preventing and treating hypertension."
08/01/2008 - "The objective of this study was to examine the effects of nattokinase supplementation on blood pressure in subjects with pre-hypertension or stage 1 hypertension. "
01/01/2011 - "The fragments, which absorbed as nattokinase-degradation products, prevents the elevation of plasma angiotensin II level to suppress hypertension."
|4.||Cardiovascular Diseases (Cardiovascular Disease)
11/01/2007 - "Nattokinase is a potent fibrinolytic enzyme with the potential for fighting cardiovascular diseases. "
03/01/2009 - "In this study, we hypothesized that nattokinase could reduce certain factors of blood clotting and lipids that are associated with an increase risk for cardiovascular disease (CVD). "
|2.||Acetic Acid (Vinegar)
|3.||red yeast rice
|4.||glucuronyl glucosamine glycan sulfate (Vessel)
|6.||Aspirin (Acetylsalicylic Acid)
|8.||Serine Proteases (Serine Protease)
|9.||Glutamic Acid (Glutamate)
|3.||Angioplasty (Angioplasty, Transluminal)